Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes.

Giulia FalconiEmiliano FabianiAlfonso PiciocchiMarianna CriscuoloLuana FianchiElisa L Lindfors RossiCarlo FinelliElisa CerquiTiziana OttoneAlfredo MolteniMatteo ParmaStella SantaroneAnna CandoniSimona SicaGiuseppe LeoneFrancesco Lo-CocoMaria Teresa Teresa Voso

Published in: Leukemia (2018)

Keyphrases

stem cell transplantation
high dose
acute myeloid leukemia
copy number
low dose
gene expression
bone marrow
dna methylation
breast cancer risk